No Detail Found!

Outcomes of Nephron-sparing Surgery in T1 vs T2 Renal Tumours

Author(s)
Pardeep Kumar Department of Urology, Sindh Institute of Urology and Transplantation,Karachi,Pakistan
Mudassir Hussain Department of Urology, Sindh Institute of Urology and Transplantation,Karachi,Pakistan
Mehnaz Jabeen Department of Urology, Sindh Institute of Urology and Transplantation,Karachi,Pakistan
Rehan Mohsin Department of Urology, Sindh Institute of Urology and Transplantation,Karachi,Pakistan
Gauhar Sultan Department of Urology, Sindh Institute of Urology and Transplantation,Karachi,Pakistan
Altaf Hashmi Department of Urology, Sindh Institute of Urology and Transplantation,Karachi,Pakistan
Abstract
Objective: To compare the drop in eGFR after nephron-sparing surgery in T1 and T2 renal tumours. Study Design: Descriptive study. Place and Duration of Study: Department of Uro-oncology, Sindh Institute of Urology, and Transplantation Karachi, from March 2020 to March 2021. Methodology: Retrospective data were collected for all patients who underwent nephron-sparing surgery between 2014 to 2019. Eighty-seven patients were divided into two groups based on the T stage of renal tumours (T1 d7 cm and T2 >7 cm). The outcomes of the two groups were compared such as eGFR, blood transfusion, hospital stay and complications. Results: There was a higher drop in eGFR in T2 tumours when compared to T1 tumours at 1 year of follow-up. There were more perioperative complications, higher blood transfusions and longer hospital stays for T2 tumours. Conclusion: Nephron sparing surgery for T2 renal tumours carries lower eGFR preservation, higher blood transfusions and complications when compared to T1 tumours. The indication for such extensive surgery should be individualized to speci c contexts only.
Publication Details
Page(s) 627-631
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 32, Issue: 5, Year: 2022

Request the full text from PASTIC

Keywords
Glomerular filtration rate, Nephrectomy, Blood transfu sion., Adenocarcinoma kidney, Length of hospital stay
0

Citations

0

Downloads

110

Views